| Ytd | 54.92% | |
| 1y | 27.77% |
| Open | 179.74 | Prev Close | 180.68 | Low | 175.71 | High | 180.35 | Mkt Cap | 11.23B |
| Vol | 573.91K | Avg Vol | 844.80K | EPS | 11.80 | P/E | 14.92 | Forward P/E | 10.20 |
| Beta | 0.87 | Short Ratio | 4.14 | Inst. Own | 49.33% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-28 | 50-d Avg | 211.44 | 200-d Avg | 162.63 | 1yr Est | 218.43 |
An aging population and growing telehealth and AI adoption support the Zacks Medical - Outpatient an
Berkshire slashed its Capital One stake by 58%, among its largest cuts, despite the stock's top
In fact, it's a healthcare company. It is a strong player in its chosen niche.
DaVita expands its Humana partnership to earlier-stage kidney disease, bringing value-based care to
SHANGHAI, Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the
Launched July 1, this partnership builds on the organizations' long-standing collaboration in en
More than 10,000 members will get added support aimed at delaying or preventing dialysis and reducin
BlackRock Inc. purchased a new position in DaVita Inc. (NYSE: DVA) during the second quarter, accord
Bank of New York Mellon Corp purchased a new stake in DaVita Inc. (NYSE: DVA) during the second quar
Bank of America Corp DE lowered its position in shares of DaVita Inc. (NYSE: DVA) by 33.4% in the fi
TD Cowen analyst Ryan Langston upgrades DaVita (NYSE:DVA) from Hold to Buy and lowers the price t
US payrolls shrank by 23K in July. Here is how weak jobs data sparked gains for tech, gold, and top
Truist Securities analyst David Macdonald maintains DaVita (NYSE:DVA) with a Hold and lowers the
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
DVA's second-quarter 2026 results show profit growth, but narrowing margins and a weaker commercial
Gold posts its biggest one-day gain since February and the Dow sets a record as Iran deal hopes cool
DaVita's Q2 earnings call highlights mortality-led volume gains and broader middle molecule access,
Wall Street analysts changed outlook on top names. UBS cut Fidelity National Information target, JP
U.S. stock futures mixed, Dow up 100 points. SpaceX stock falls 10.3% after reporting strong Q2 reve
Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price
DaVita NYSE: DVA reported second-quarter results that management said were broadly in line with expe
Adjusted Operating Income: $579 million in Q2 2026.Adjusted Earnings Per Share: $4.02 in Q2 2026.Fre
DaVita Inc. (DVA) Q2 2026 Earnings Call Transcript
DaVita said on Tuesday revenue per treatment was lower in the second quarter, blaming declining enr
DaVita HealthCare (DVA) came out with quarterly earnings of $4.02 per share, beating the Zacks Conse
On August 4, 2026, DaVita Inc (DVA) released its 8-K filing, revealing financial and operational res
DaVita (NYSE:DVA) reported quarterly earnings of $4.02 per share which beat the analyst consensus es
DENVER, Aug. 4, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating resul
DVA's Q2 results are likely to benefit from volume growth and RPT recovery, but payor mix pressure a
DVA's IKC momentum, higher 2026 guidance and technology investments support growth, while reimbursem
Truist Securities analyst David Macdonald maintains DaVita (NYSE:DVA) with a Hold and raises the
Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
TD Cowen analyst Ryan Langston maintains DaVita (NYSE:DVA) with a Hold and raises the price targe
Truist Securities analyst David Macdonald maintains DaVita (NYSE:DVA) with a Hold and raises the
Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price
U.S. stocks hit records as Trump's Iran memo sinks oil 6%, AMD soars 17% on data-center beat.
Top Wall Street analysts upgraded several top stocks. See all changes and ratings on Benzinga's
Dow Jones up 500 points, DaVita Inc (DVA) shares rise after better-than-expected earnings and raised
Deutsche Bank analyst Pito Chickering upgrades DaVita (NYSE:DVA) from Hold to Buy and raises the
DaVita (NYSE:DVA) reported quarterly earnings of $2.87 per share which beat the analyst consensus es
The latest 13F filing from Berkshire Hathaway reveals some of the final position changes made by War
Wall Street extended losses into midday trading Tuesday as geopolitical tensions in the Middle East
DaVita stock surged after the kidney care provider beat earnings estimates and issued strong 2026 gu
Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price